Investigating the potential of azaphilone compounds for therapeutic use
Late-stage functionalization and bioactivity investigation of azaphilone compounds
This study is working on a new way to make special natural compounds that could help treat infections and inflammation, making it easier for doctors to use them in medicine.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10998541 on NIH RePORTER |
What this research studies
This research focuses on developing efficient methods to synthesize azaphilone compounds, which are natural products known for their medicinal properties. By utilizing biocatalysis and P450 enzymes, the project aims to create a high-throughput approach to produce these compounds, which have shown promise in treating various conditions such as bacterial infections and inflammation. The goal is to make these potentially life-saving therapeutics more accessible for testing and use in medical treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that may benefit from new antibacterial or anti-inflammatory treatments.
Not a fit: Patients who are not affected by bacterial infections or inflammatory conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapeutic options for patients suffering from bacterial infections, inflammation, and other related conditions.
How similar studies have performed: Previous research has shown success in utilizing natural products for therapeutic development, indicating a promising avenue for this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Torma, Katherine Jane — University of Michigan at Ann Arbor
- Study coordinator: Torma, Katherine Jane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.